M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Telix Pharmaceuticals delivers first commercial doses from Belgian manufacturing hub
Biopharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX) (NASDAQ: TLX) announced on Wednesday that its Telix Manufacturing Solutions (TMS) facility in Brussels South (Seneffe), Belgium has completed the first commercial delivery of Good Manufacturing Practice (GMP)-grade...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search